United States · FDA National Drug Code directory
EYLEA HD
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61755-051_c6550964-b64e-42e9-a3b2-dd682b1dfbbc
- Product NDC
- 61755-051
- Form
- INJECTION, SOLUTION
- Composition / generic term
- aflibercept
- Labeler
- Regeneron Pharmaceuticals, Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20230818
- Source listing expiry
- 20271231
Source-listed ingredients
- AFLIBERCEPT — 8 mg/.07mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-051-01) / .07 mL in 1 VIAL, SINGLE-DOSE (61755-051-00) · 61755-051-01
- 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-051-51) / .07 mL in 1 VIAL, SINGLE-DOSE (61755-051-50) · 61755-051-51
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →